These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15140412)

  • 41. Activation of protease-activated receptors in astrocytes evokes a novel neuroprotective pathway through release of chemokines of the growth-regulated oncogene/cytokine-induced neutrophil chemoattractant family.
    Wang Y; Luo W; Reiser G
    Eur J Neurosci; 2007 Dec; 26(11):3159-68. PubMed ID: 18005059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protease activated receptors: clinical relevance to hemostasis and inflammation.
    Landis RC
    Hematol Oncol Clin North Am; 2007 Feb; 21(1):103-13. PubMed ID: 17258121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Agonists of proteinase-activated receptor-2 modulate human neutrophil cytokine secretion, expression of cell adhesion molecules, and migration within 3-D collagen lattices.
    Shpacovitch VM; Varga G; Strey A; Gunzer M; Mooren F; Buddenkotte J; Vergnolle N; Sommerhoff CP; Grabbe S; Gerke V; Homey B; Hollenberg M; Luger TA; Steinhoff M
    J Leukoc Biol; 2004 Aug; 76(2):388-98. PubMed ID: 15155775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The cardiovascular actions of protease-activated receptors.
    Steinberg SF
    Mol Pharmacol; 2005 Jan; 67(1):2-11. PubMed ID: 15371558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coagulation and fibrosis in chronic liver disease.
    Calvaruso V; Maimone S; Gatt A; Tuddenham E; Thursz M; Pinzani M; Burroughs AK
    Gut; 2008 Dec; 57(12):1722-7. PubMed ID: 19022928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Characteristic properties of thrombin neurotropic activity].
    Balezina OP; Gerasimenko NIu; Dugina TN; Strukova SM
    Usp Fiziol Nauk; 2004; 35(3):37-49. PubMed ID: 15455552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
    Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF
    Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protease-activated receptors in the musculoskeletal system.
    Mackie EJ; Loh LH; Sivagurunathan S; Uaesoontrachoon K; Yoo HJ; Wong D; Georgy SR; Pagel CN
    Int J Biochem Cell Biol; 2008; 40(6-7):1169-84. PubMed ID: 18243039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proteinase-activated receptors in the lower urinary tract.
    Moffatt JD
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):1-9. PubMed ID: 17294233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physiology and pathophysiology of proteinase-activated receptors (PARs): regulation of the expression of PARs.
    Hirano K; Yufu T; Hirano M; Nishimura J; Kanaide H
    J Pharmacol Sci; 2005 Jan; 97(1):31-7. PubMed ID: 15655296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteinase-activated receptor 2 activation in the airways enhances antigen-mediated airway inflammation and airway hyperresponsiveness through different pathways.
    Ebeling C; Forsythe P; Ng J; Gordon JR; Hollenberg M; Vliagoftis H
    J Allergy Clin Immunol; 2005 Mar; 115(3):623-30. PubMed ID: 15753914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CXCR2 antagonists for the treatment of pulmonary disease.
    Chapman RW; Phillips JE; Hipkin RW; Curran AK; Lundell D; Fine JS
    Pharmacol Ther; 2009 Jan; 121(1):55-68. PubMed ID: 19026683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Getting the message across: pathophysiology and signaling via receptors for polypeptide hormones and proteinases.
    Hollenberg MD
    Clin Invest Med; 2010 Apr; 33(2):E133. PubMed ID: 20370993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do heterotrimeric G proteins redistribute upon G protein-coupled receptor stimulation in platelets?
    Kahner BN; Quinton TM; Langan S; Kunapuli SP
    Platelets; 2006 Sep; 17(6):397-404. PubMed ID: 16973501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?
    Becker J; Delayre-Orthez C; Frossard N; Pons F
    Fundam Clin Pharmacol; 2006 Oct; 20(5):429-47. PubMed ID: 16968414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelins and airways--a short review.
    Polikepahad S; Moore RM; Venugopal CS
    Res Commun Mol Pathol Pharmacol; 2006; 119(1-6):3-51. PubMed ID: 17974095
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evolution of the protease-activated receptor family in vertebrates.
    Jin M; Yang HW; Tao AL; Wei JF
    Int J Mol Med; 2016 Mar; 37(3):593-602. PubMed ID: 26820116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Up-regulation of protease activated receptors in bladder after cyclophosphamide induced cystitis and colocalization with capsaicin receptor (VR1) in bladder nerve fibers.
    Dattilio A; Vizzard MA
    J Urol; 2005 Feb; 173(2):635-9. PubMed ID: 15643279
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteinases as hormone-like signal messengers.
    Hollenberg MD; Houle S
    Swiss Med Wkly; 2005 Jul; 135(29-30):425-32. PubMed ID: 16208579
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Proteinase-activated receptor].
    Matsunami M; Sekiguchi T; Kawabata A
    Nihon Yakurigaku Zasshi; 2006 Dec; 128(6):434-6. PubMed ID: 17260456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.